Core Scientific (CORZZ) Cost of Revenue (2021 - 2026)

Core Scientific's Cost of Revenue history runs 6 years deep, the most recent figure standing at $85.1 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 19.39% year-over-year to $85.1 million; the TTM figure through Mar 2026 stood at $294.9 million (down 17.9% YoY), while the FY2025 annual figure was $281.1 million, down 27.84% from the prior year.
• Cost of Revenue came in at $85.1 million for Q1 2026 at Core Scientific, up from $59.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $375.8 million in Q4 2023 to a low of -$450.7 million in Q4 2022.
• A 5-year average of $57.3 million and a median of $77.2 million in 2025 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue plunged 219.34% in 2022 and jumped 9335.89% in 2024, its largest moves.
• Core Scientific's Cost of Revenue stood at -$450.7 million in 2022, then surged by 183.39% to $375.8 million in 2023, then tumbled by 76.01% to $90.2 million in 2024, then slumped by 34.55% to $59.0 million in 2025, then soared by 44.28% to $85.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $85.1 million, $59.0 million, and $77.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison